{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:44:03Z","timestamp":1781761443372,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jdin.2022.06.012","type":"journal-article","created":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T01:09:23Z","timestamp":1655600963000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["\u201cCOVID toes\u201d: A true viral phenomenon or a diagnosis without a leg to stand on?"],"prefix":"10.1016","volume":"9","author":[{"given":"Jia C.","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankuri","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Safai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8489-961X","authenticated-orcid":false,"given":"Shoshana","family":"Marmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jdin.2022.06.012_bib25","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jdin.2022.06.012_bib26","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/jdv.16387","article-title":"Cutaneous manifestations in COVID-19: a first perspective","volume":"34","author":"Recalcati","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jdin.2022.06.012_bib1","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.jaad.2020.04.093","article-title":"Characterization of acute acral skin lesions in nonhospitalized patients: a case series of 132 patients during the COVID-19 outbreak","volume":"83","author":"Fernandez-Nieto","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.06.012_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galv\u00e1n Casas","year":"2020","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.06.012_bib3","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jaad.2020.11.003","article-title":"The underrepresentation of \u201cCOVID toes\u201d in skin of color: an example of racial bias or evidence of a tenuous disease association?","volume":"84","author":"Cline","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.06.012_bib4","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.jaad.2020.09.030","article-title":"Absence of specific cutaneous manifestations of severe acute respiratory syndrome coronavirus 2 in a reference center in Brazil","volume":"84","author":"Avancini","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2022.06.012_bib5","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1016\/j.jaad.2020.07.037","article-title":"COVID toes: phenomenon or epiphenomenon?","volume":"83","author":"Deutsch","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jdin.2022.06.012_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamadermatol.2021.2120","article-title":"Epidemiologic analysis of chilblains cohorts before and during the COVID-19 pandemic","volume":"157","author":"McCleskey","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdin.2022.06.012_bib27","author":"Rabin"},{"key":"10.1016\/j.jdin.2022.06.012_bib28","author":"Lipper"},{"issue":"1","key":"10.1016\/j.jdin.2022.06.012_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ced.14421","article-title":"Recognizable vascular skin manifestations of SARS-CoV-2 (COVID-19) infection are uncommon in patients with darker skin phototypes","volume":"46","author":"Pangti","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jdin.2022.06.012_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jdin.2020.12.003","article-title":"Skin manifestations of COVID-19: a worldwide review","volume":"2","author":"Tan","year":"2021","journal-title":"JAAD Int"},{"key":"10.1016\/j.jdin.2022.06.012_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijid.2020.10.021","article-title":"COVID toes: where do we stand with the current evidence?","volume":"102","author":"Baeck","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.jdin.2022.06.012_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00011-020-01370-w","article-title":"Are the cutaneous manifestations during or due to SARS-CoV-2 infection\/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms","volume":"69","author":"Criado","year":"2020","journal-title":"Inflamm Res"},{"issue":"4","key":"10.1016\/j.jdin.2022.06.012_bib30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.det.2021.05.003","article-title":"Coronavirus disease 2019 and race in dermatology","volume":"39","author":"Desai","year":"2021","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jdin.2022.06.012_bib31","series-title":"COVID-19: cutaneous manifestations and issues related to dermatologic care","author":"Feldman","year":"2021"},{"issue":"5","key":"10.1016\/j.jdin.2022.06.012_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bjd.19807","article-title":"Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection","volume":"184","author":"Visconti","year":"2021","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.06.012_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jamadermatol.2020.4324","article-title":"Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic","volume":"157","author":"Hubiche","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.jdin.2022.06.012_bib14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jamadermatol.2020.2368","article-title":"Evaluation of chilblains as a manifestation of the COVID-19 pandemic","volume":"156","author":"Herman","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2022.06.012_bib16","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/jdv.16682","article-title":"A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection","volume":"34","author":"El Hachem","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jdin.2022.06.012_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1473-3099(20)30518-1","article-title":"Negative SARS-CoV-2 PCR in patients with chilblain-like lesions","volume":"21","author":"Hubiche","year":"2021","journal-title":"Lancet Infectious Dis"},{"issue":"4","key":"10.1016\/j.jdin.2022.06.012_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjd.19327","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2022.06.012_bib19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/cup.13830","article-title":"Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2","volume":"47","author":"Ko","year":"2020","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.jdin.2022.06.012_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.11369","article-title":"Bilateral Chilblain-like lesions of the toes characterized by microvascular remodeling in adolescents during the COVID-19 pandemic","volume":"4","author":"Discepolo","year":"2021","journal-title":"JAMA Network Open"},{"issue":"10251","key":"10.1016\/j.jdin.2022.06.012_bib20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0140-6736(20)31754-2","article-title":"SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report","volume":"396","author":"Jamiolkowski","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jdin.2022.06.012_bib22","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/bjd.20707","article-title":"Type I interferon response and vascular alteration in chilblain-like lesions during\u00a0the COVID-19 outbreak","volume":"185","author":"Frumholtz","year":"2021","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.06.012_bib32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaci.2020.04.029","article-title":"Type I IFN immunoprofiling in COVID-19 patients","volume":"146","author":"Trouillet-Assant","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"6504","key":"10.1016\/j.jdin.2022.06.012_bib33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jdin.2022.06.012_bib34","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.jaad.2020.06.052","article-title":"When interferon tiptoes through COVID-19: pernio-like lesions and their prognostic implications during SARS-CoV-2 infection","volume":"83","author":"Damsky","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jdin.2022.06.012_bib35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122090119","article-title":"Lack of association between pandemic chilblains and SARS-CoV-2 infection","volume":"119","author":"Gehlhausen","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.jdin.2022.06.012_bib23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaad.2020.06.1018","article-title":"New insights in COVID-19-associated chilblains: a comparative study with chilblain lupus erythematosus","volume":"83","author":"Battesti","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2022.06.012_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00258-20","article-title":"Epstein-Barr virus (EBV) tegument protein BGLF2 suppresses type I interferon signaling to promote EBV reactivation","volume":"94","author":"Liu","year":"2020","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.jdin.2022.06.012_bib36","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1016\/j.jaip.2021.05.030","article-title":"\u201cCOVID Toes\u201d after mRNA COVID-19 vaccines","volume":"9","author":"Kelso","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.jdin.2022.06.012_bib37","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1111\/jdv.17451","article-title":"Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that \u2018COVID toes\u2019 are due to the immune reaction to SARS-CoV-2","volume":"35","author":"Lesort","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdin.2022.06.012_bib38","doi-asserted-by":"crossref","first-page":"taab024","DOI":"10.1093\/jtm\/taab024","article-title":"\u2018Blue toes\u2019 following vaccination with the BNT162b2 mRNA COVID-19 vaccine","volume":"28","author":"Davido","year":"2021","journal-title":"J Travel Med"},{"issue":"11","key":"10.1016\/j.jdin.2022.06.012_bib39","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3888","article-title":"Type I interferon signature in chilblains following SARS-CoV-2 mRNA vaccine: a case report","volume":"101","author":"Souaid","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jdin.2022.06.012_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.06.012_bib41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jdv.17744","article-title":"Cutaneous findings following COVID-19 vaccination: review of world literature and own experience","volume":"36","author":"Gambichler","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jdin.2022.06.012_bib42","author":"Salamon"},{"issue":"6","key":"10.1016\/j.jdin.2022.06.012_bib43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/pathogens10060763","article-title":"Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation","volume":"10","author":"Gold","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.jdin.2022.06.012_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jdcr.2021.03.032","article-title":"Skin manifestations of suspected COVID-19: complications of the disease or reactivation of latent viral infections?","volume":"12","author":"Sugawara-Mikami","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"5","key":"10.1016\/j.jdin.2022.06.012_bib45","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jdin.2022.06.012_bib46","author":"Belluck"},{"issue":"2","key":"10.1016\/j.jdin.2022.06.012_bib11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2020.05.109","article-title":"Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328722000827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328722000827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:00:42Z","timestamp":1762981242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328722000827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":44,"alternative-id":["S2666328722000827"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2022.06.012","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cCOVID toes\u201d: A true viral phenomenon or a diagnosis without a leg to stand on?","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2022.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}